C4 Therapeutics to Present at Bank of America Securities Precision Oncology Conference 2022
WATERTOWN, Mass., Sept. 26, 2022 (GLOBE NEWSWIRE) — C4 Therapeutics, Inc. (C4T) (Nasdaq:CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science to develop a new generation of small-molecule medicines and transform how disease is treated, today announced that C4T management will participate in a fireside chat at the virtual Bank of America Securities Precision Oncology Conference 2022.
Related news for (CCCC)
- C4 Therapeutics Teams Up with Pfizer on New Myeloma Combo Trial
- From SaaS to Semis: Market Signals Big Moves Ahead
- MoBot alert highlights: NYSE: MSN, NASDAQ: ADAP, NASDAQ: CCCC, NASDAQ: RCEL, NASDAQ: PTNM (09/15/25 12:00 PM)
- MoBot’s Stock Market Highlights – 09/15/25 11:00 AM
- MoBot’s Stock Market Highlights – 09/15/25 10:00 AM